Description

Methyl 6-(2-Furyl)-3-Methylisoxazolo[5,4-B]Pyridine-4-Carboxylate is a high-purity, advanced pharmaceutical intermediate belonging to the fused isoxazolopyridine class of heterocyclic compounds. Its complex molecular architecture makes it a critical building block for the synthesis of novel active pharmaceutical ingredients (APIs) with targeted biological activity. This compound is essential for research and development chemists in the pharmaceutical and agrochemical industries, particularly those focused on creating new therapeutic agents or crop protection solutions.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, inflammatory diseases, or oncology.
• Agrochemical Research: Used in the development of new-generation pesticides and herbicides, leveraging its heterocyclic core for bioactivity.
• Chemical Biology & Medicinal Chemistry: A valuable scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Organic Synthesis Building Block: Employed in complex multi-step organic syntheses to construct more elaborate molecular architectures.
• Academic & Contract Research: Utilized in university and CRO (Contract Research Organization) laboratories for fundamental research on heterocyclic chemistry and its applications.

Basic Information

Product Name	Methyl 6-(2-Furyl)-3-Methylisoxazolo[5,4-B]Pyridine-4-Carboxylate
CAS No.	938006-78-1
Molecular Formula	C14H12N2O4
Molecular Weight	272.26 g/mol
Synonyms	Methyl 6-(2-furanyl)-3-methylisoxazolo[5,4-b]pyridine-4-carboxylate; 6-(2-Furyl)-3-methylisoxazolo[5,4-b]pyridine-4-carboxylic acid methyl ester; 4-Carbomethoxy-6-(2-furyl)-3-methylisoxazolo[5,4-b]pyridine; 938006-78-1; Isoxazolo[5,4-b]pyridine-4-carboxylic acid, 6-(2-furanyl)-3-methyl-, methyl ester
EINECS	Contact for details

Quality Control

Our production of Methyl 6-(2-Furyl)-3-Methylisoxazolo[5,4-B]Pyridine-4-Carboxylate adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with every shipment, confirming compliance with agreed specifications. Our quality system is designed to support cGMP requirements for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.